Type 2 Diabetes

Certain inflammatory biomarkers may help lead to improvements in the treatment of diabetes. 

Hypertension, obesity, and diabetes found to be the most prevalent comorbidities among 5700 hospitalized patients with COVID-19 in the New York City Area. 

The familiarity of using hemoglobin A1C value to guide control in patients with type 2 diabetes is known, but how do these longitudinal values relate to cardiovascular outcomes?

Arterial stiffness is a complication of cardiovascular disease; does skipping meals contribute to this condition in patients with type 2 diabetes mellitus?

Minimization of secondary diabetic complications from early glycemic control in type 2 diabetes patients. 

Can cholesteryl ester transfer protein inhibitors reduce incident type 2 diabetes? 

Patients with prediabetes show differences in human host markers and gut microbiome compared to healthy patients. 

Adults who have diabetes are two times more likely to die from heart disease and stroke, and younger people with diabetes are at risk of earlier heart disease. 

The majority of patients with type 2 diabetes fail to maintain glycemic goals over time after initial success with standard interventions. 

A middle-aged woman, with mild obesity and type 2 diabetes, was hospitalized in the ICU, and the order on her chart was documented "Lispro 90 units at HS," then the "9" was crossed off and a "6" written above it....